Market Research Logo

US Procedure Numbers for Urological Devices 2016 - MedPro

US Procedure Numbers for Urological Devices 2016 - MedPro

Urological procedures are driven primarily by the aging a population, as most urological disorders increase in prevalence with age. However, each area is also governed by different market dynamics that affect the level of growth exhibited by each procedure type. For example, lawsuits and negative press in the female urinary incontinence sling market has caused it experience dramatic declines, while an increasing prevalence of bladder cancer is driving nephrostomy procedures.The procedures covered in this report suite includes urinary incontinence, stone management, benign prostate hyperplasia (BPH), prostate cancer treatment, urodynamic testing, nephrostomy and erectile dysfunction management procedures. Each category is further segmented into more specific procedure types.


EXECUTIVE SUMMARY
1.1 U.S. UROLOGICAL DEVICE MARKET OVERVIEW
1.2 COMPETITIVE ANALYSIS
1.3 MARKET TRENDS
1.4 MARKETS INCLUDED
1.5 PROCEDURE NUMBERS
1.6 PROCEDURE CODES INVESTIGATED
1.7 MARKET DEVELOPMENTS
1.8 KEY REPORT UPDATES
1.9 VERSION HISTORY
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PROCEDURE NUMBERS
3.1 PROCEDURE CODES INVESTIGATED
3.2 PROCEDURE OVERVIEW
3.3 URINARY INCONTINENCE PROCEDURES
3.3.1 Male Incontinence Management Procedures
3.3.1.1 Male Incontinence Sling Procedures
3.3.1.2 Male Incontinence Sling Removal Procedures
3.3.1.3 Male Artificial Urinary Sphincter Procedures
3.3.2 Female Incontinence Management Procedures
3.3.2.1 Transvaginal Tape Female Incontinence Sling Procedures
3.3.2.2 Transobturator Female Incontinence Sling Procedures
3.3.2.3 Single-Incision Female Incontinence Sling Procedures
3.3.2.4 Female Incontinence Sling Removal Procedures
3.3.2.5 Female Urethral Suspension Procedures
3.4 STONE MANAGEMENT PROCEDURES
3.4.1 ESWL Procedures
3.4.2 Transurethral Procedures
3.4.2.1 Lithotripsy Procedures
3.4.2.2 Non-Lithotripsy Procedures
3.4.3 Ureteral Stent Placement Procedures
3.4.4 PCNL Procedures
3.5 BPH PROCEDURES
3.5.1 BPH Patient Statistics
3.5.2 BPH Procedures
3.5.2.1 TURP Procedures
3.5.2.2 Laser BPH Procedures
3.5.2.3 Prostatic Stent Placement Procedures
3.5.2.4 TUMT Procedures
3.5.2.5 TUNA Procedures
3.5.2.6 Botox® Injection Procedures
3.6 PROSTATE CANCER TREATMENT PROCEDURES
3.6.1 Prostate Cancer Statistics
3.6.2 Prostate Cancer Treatment Procedures
3.6.2.1 Watchful Waiting
3.6.2.2 Prostatectomy Procedures
3.6.2.2.1 Open Prostatectomy Procedures
3.6.2.2.2 Laparoscopic Prostatectomy Procedures
3.6.2.2.3 Robotic Prostatectomy Procedures
3.6.3 Prostate Ablation Procedures
3.6.3.1 Cryotherapy Tumor Ablation Procedures
3.6.3.2 Microwave Tumor Ablation Procedures
3.6.3.3 RF Tumor Ablation Procedures
3.6.4 Radiation Therapy Procedures
3.6.4.1 Prostate HDR Brachytherapy Procedures
3.6.4.2 Prostate LDR Brachytherapy Procedures
3.6.4.2.1 Cs-131 Procedures
3.6.4.2.2 Pd-103 Procedures
3.6.4.2.3 I-125 Procedures
3.6.4.3 External Radiation Therapy Procedures
3.6.4.3.1 Linear Accelerator Procedures
3.6.4.3.2 Proton Therapy Procedures
3.7 URODYNAMIC TESTING PROCEDURES
3.7.1 Cystometrogram Procedures
3.7.1.1 Simple Cystometrogram Procedures
3.7.1.2 Complex Cystometrogram Procedures
3.7.2 Uroflowmetry Procedures
3.7.2.1 Simple Uroflowmetry Procedures
3.7.2.2 Complex Uroflowmetry Procedures
3.8 NEPHROSTOMY PROCEDURES
3.8.1 Nephrostomy/Nephrotomy Procedures
3.8.2 Percutaneous Nephrostomy Procedures
3.9 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES
3.9.1 Insertion of Inflatable ED Device Procedures
3.9.2 Insertion of Malleable ED Device Procedures
3.9.3 Removal of ED Device Procedures
ABBREVIATIONS
LIDT OF CHART
Chart 1 1: Urological Device Market by Segment, U.S., 2012 – 2022
Chart 1 2: Urological Device Market Overview, 2015 and 2022
Chart 3 1: Urological Procedures by Type, U.S., 2012 – 2022
Chart 3 2: Urinary Incontinence Procedures by Type, U.S., 2012 – 2022
Chart 3 3: Male Incontinence Management Procedures by Type, U.S., 2012 – 2022
Chart 3 4: Female Incontinence Management Procedures by Type, U.S., 2012 – 2022
Chart 3 5: Stone Management Procedures by Type, U.S., 2012 – 2022
Chart 3 6: ESWL Procedures, U.S., 2012 – 2022
Chart 3 7: Transurethral Procedures by Type, U.S., 2012 – 2022
Chart 3 8: Ureteral Stent Placement Procedures, U.S., 2012 – 2022
Chart 3 9: PCNL Procedures, U.S., 2012 – 2022
Chart 3 10: BPH Patient Statistics, U.S., 2012 – 2022
Chart 3 11: BPH Procedures by Type, U.S., 2012 – 2022
Chart 3 12: TURP Procedures, U.S., 2012 – 2022
Chart 3 13: Laser BPH Procedures, U.S., 2012 – 2022
Chart 3 14: Prostatic Stent Placement Procedures, U.S., 2012 – 2022
Chart 3 15: TUMT Procedures, U.S., 2012 – 2022
Chart 3 16: TUNA Procedures, U.S., 2012 – 2022
Chart 3 17: Botox® Injection Procedures, U.S., 2012 – 2022
Chart 3 18: Prostate Cancer Statistics, U.S., 2012 – 2022
Chart 3 19: Prostate Cancer Treatment Procedures by Type, U.S., 2012 – 2022
Chart 3 20: Watchful Waiting, U.S., 2012 – 2022
Chart 3 21: Prostatectomy Procedures by Approach, U.S., 2012 – 2022
Chart 3 22: Open Prostatectomy Procedures by Type, U.S., 2012 – 2022
Chart 3 23: Prostate Ablation Procedures by Modality, U.S., 2012 – 2022
Chart 3 24: Radiation Therapy Procedures by Modality, U.S., 2012 – 2022
Chart 3 25: Prostate HDR Brachytherapy Procedures, U.S., 2012 – 2022
Chart 3 26: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 – 2022
Chart 3 27: External Radiation Therapy Procedures by Modality, U.S., 2012 – 2022
Chart 3 28: Urodynamic Testing Procedures by Type, U.S., 2012 – 2022
Chart 3 29: Cystometrogram Procedures by Type, U.S., 2012 – 2022
Chart 3 30: Uroflowmetry Procedures by Type, U.S., 2012 – 2022
Chart 3 31: Nephrostomy Procedures by Type, U.S., 2012 – 2022
Chart 3 32: Nephrostomy/Nephrotomy Procedures, U.S., 2012 – 2022
Chart 3 33: Percutaneous Nephrostomy Procedures, U.S., 2012 – 2022
Chart 3 34: Erectile Dysfunction Management Procedures by Type, U.S., 2012 – 2022
Chart 3 35: Insertion of Inflatable ED Device Procedures, U.S., 2012 – 2022
Chart 3 36: Insertion of Malleable ED Device Procedures, U.S., 2012 – 2022
Chart 3 37: Removal of ED Device Procedures, U.S., 2012 – 2022
LIST OF FIGURES
Figure 1 1: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 1 2: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2015
Figure 1 4: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Urological Markets Covered, U.S., 2015 (1 of 5)
Figure 1 7: Urological Markets Covered, U.S., 2015 (2 of 5)
Figure 1 8: Urological Markets Covered, U.S., 2015 (3 of 5)
Figure 1 9: Urological Markets Covered, U.S., 2015 (4 of 5)
Figure 1 10: Urological Markets Covered, U.S., 2015 (5 of 5)
Figure 1 11: Urological Procedures Covered, U.S., 2015 (1 of 2)
Figure 1 12: Urological Procedures Covered, U.S., 2015 (2 of 2)
Figure 1 13: Procedural Codes Investigated, U.S., 2015
Figure 1 14: Recent Events in the Urological Device Market, U.S., 2012 - 2015
Figure 1 15: Key Report Updates
Figure 1 16: Version History
Figure 3 1: Procedural Codes Investigated (1 of 2)
Figure 3 2: Procedural Codes Investigated (1 of 2)
Figure 3 3: Urological Procedures by Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 4: Urological Procedures by Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 5: Urinary Incontinence Procedures by Type, U.S., 2012 – 2022
Figure 3 6: Male Incontinence Management Procedures by Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 7: Male Incontinence Management Procedures by Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 8: Female Incontinence Management Procedures by Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 9: Female Incontinence Management Procedures by Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 10: Stone Management Procedures by Type, U.S., 2012 – 2022
Figure 3 11: ESWL Procedures, U.S., 2012 – 2022
Figure 3 12: Transurethral Procedures by Type, U.S., 2012 – 2022
Figure 3 13: Ureteral Stent Placement Procedures, U.S., 2012 – 2022
Figure 3 14: PCNL Procedures, U.S., 2012 – 2022
Figure 3 15: BPH Patient Statistics, U.S., 2012 – 2022
Figure 3 16: BPH Procedures by Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 17: BPH Procedures by Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 18: TURP Procedures, U.S., 2012 – 2022
Figure 3 19: Laser BPH Procedures, U.S., 2012 – 2022
Figure 3 20: Prostatic Stent Placement Procedures, U.S., 2012 – 2022
Figure 3 21: TUMT Procedures, U.S., 2012 – 2022
Figure 3 22: TUNA Procedures, U.S., 2012 – 2022
Figure 3 23: Botox® Injection Procedures, U.S., 2012 – 2022
Figure 3 24: Prostate Cancer Statistics, U.S., 2012 – 2022
Figure 3 25: Prostate Cancer Treatment Procedures by Type, U.S., 2012 – 2022
Figure 3 26: Watchful Waiting, U.S., 2012 – 2022
Figure 3 27: Prostatectomy Procedures by Approach, U.S., 2012 – 2022 (1 of 2)
Figure 3 28: Prostatectomy Procedures by Approach, U.S., 2012 – 2022 (2 of 2)
Figure 3 29: Open Prostatectomy Procedures by Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 30: Open Prostatectomy Procedures by Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 31: Prostate Ablation Procedures by Modality, U.S., 2012 – 2022 (1 of 2)
Figure 3 32: Prostate Ablation Procedures by Modality, U.S., 2012 – 2022 (2 of 2)
Figure 3 33: Radiation Therapy Procedures by Modality, U.S., 2012 – 2022
Figure 3 34: Prostate HDR Brachytherapy Procedures, U.S., 2012 – 2022
Figure 3 35: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 – 2022 (1 of 2)
Figure 3 36: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 – 2022 (2 of 2)
Figure 3 37: External Radiation Therapy Procedures by Modality, U.S., 2012 – 2022
Figure 3 38: Urodynamic Testing Procedures by Type, U.S., 2012 – 2022
Figure 3 39: Cystometrogram Procedures by Type, U.S., 2012 – 2022
Figure 3 40: Uroflowmetry Procedures by Type, U.S., 2012 – 2022
Figure 3 41: Nephrostomy Procedures by Type, U.S., 2012 – 2022
Figure 3 42: Nephrostomy/Nephrotomy Procedures, U.S., 2012 – 2022
Figure 3 43: Percutaneous Nephrostomy Procedures, U.S., 2012 – 2022
Figure 3 44: Erectile Dysfunction Management Procedures by Type, U.S., 2012 – 2022
Figure 3 45: Insertion of Inflatable ED Device Procedures, U.S., 2012 – 2022
Figure 3 46: Insertion of Malleable ED Device Procedures, U.S., 2012 – 2022
Figure 3 47: Removal of ED Device Procedures, U.S., 2012 – 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report